Treatment resistance analysis reveals GLUT-1-mediated glucose uptake as a major target of synthetic rocaglates in cancer cells.
Sieber-Frank J, Stark HJ, Kalteis S, Prigge ES, Köhler R, Andresen C, Henkel T, Casari G, Schubert T, Fischl W, Li-Weber M, Krammer PH, von Knebel Doeberitz M, Kopitz J, Kloor M, Ahadova A.
Sieber-Frank J, et al. Among authors: stark hj.
Cancer Med. 2021 Oct;10(19):6807-6822. doi: 10.1002/cam4.4212. Epub 2021 Sep 20.
Cancer Med. 2021.
PMID: 34546000
Free PMC article.